| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/04/2009 | CN101375906A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375905A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375904A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375903A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375902A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375901A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375900A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375899A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375898A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375897A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375896A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375895A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375894A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375893A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375892A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375891A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375890A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375889A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375888A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375887A Pharmaceutical combination for preventing birth-defect and improving memory and intelligence |
| 03/04/2009 | CN101375886A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375885A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375884A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375883A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375882A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375881A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375880A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375879A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375878A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375877A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375876A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375875A Pharmaceutical combination for preventing birth-defect and improving memory and intelligence |
| 03/04/2009 | CN101375874A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375872A Novel medicament prescription for treating diabetes |
| 03/04/2009 | CN101375864A Biological products with treatment use and preparation method thereof |
| 03/04/2009 | CN101375840A Application of monocyclic monoterpene compounds in preparing medicament for treating diabetes |
| 03/04/2009 | CN101375718A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375717A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN100465184C Gangliosides with a modified acyl function |
| 03/04/2009 | CN100464781C Nutrition liquid for chronic nephropathy and a preparation method thereof |
| 03/04/2009 | CN100464772C A traditional Chinese medicine composition for treating diabetes |
| 03/04/2009 | CN100464764C A composition of white mulberry leaf blood-sugar-reducing effective components and a preparation method thereof |
| 03/04/2009 | CN100464757C A method for preparing hirudin by using leech bloodsuckers as the raw material |
| 03/04/2009 | CN100464754C Acarbose medicine compositions and a preparation method thereof |
| 03/04/2009 | CN100464647C A medical agent with amino acids that can increase body temperatures and be used in foods or beverages |
| 03/03/2009 | US7498417 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy |
| 03/03/2009 | US7498415 Culturing, gene expression, transformation; fab and fv fragments; biodrugs; anticarcinogenic agents, diabetes, acromegaly |
| 03/03/2009 | US7498406 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 03/03/2009 | US7498358 Human ADAM-10 inhibitors |
| 03/03/2009 | US7498335 Method of producing an antiangiogenic or vascular permeability reducing effect |
| 03/03/2009 | US7498334 Pyrrolopyrimidines as phosphodiesterase VII inhibitors |
| 03/03/2009 | US7498323 Spiro-piperidine compounds and medicinal use thereof |
| 03/03/2009 | US7498313 Large circular target-specific antisense nucleic acid compounds |
| 03/03/2009 | US7498308 The analogs are resistant to diaminopeptidase IV degradation and bind zinc; are active over an extended time in vivo |
| 03/03/2009 | US7498157 Polypeptide crystal having a polyhistidine tag added to the C-terminal end; effectors; drug screening for enzyme inhibitors; multiple sclerosis, diabetes, Grave's disease, rheumatic arthritis, AIDS, cancer, immunomodulators |
| 03/03/2009 | US7498147 Modulating the activity of one or more elements in the complement/lipid pathway |
| 03/03/2009 | US7498143 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 03/03/2009 | US7498034 Imaging, diagnosis and treatment of disease |
| 03/03/2009 | CA2410880C 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 02/28/2009 | CA2639129A1 Use |
| 02/26/2009 | WO2009026558A1 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
| 02/26/2009 | WO2009026368A2 Composition and method for managing blood glucose levels, insulin levels and/or insulin receptor functionality |
| 02/26/2009 | WO2009025478A1 Indole and indazole compounds as an inhibitor of cellular necrosis |
| 02/26/2009 | WO2009025477A1 Indole compounds as an inhibitor of cellular necrosis |
| 02/26/2009 | WO2009025315A1 Oral preparation for improvement of bioavailability of curcumin |
| 02/26/2009 | WO2009024906A1 4-pyrimidinesulfamide derivative |
| 02/26/2009 | WO2009024821A2 Oxadiazole derivatives as dgat inhibitors |
| 02/26/2009 | WO2009024287A2 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof |
| 02/26/2009 | WO2009024175A1 Herbal formulations for controlling blood glucose levels in patients with diabetes |
| 02/26/2009 | WO2009024015A1 A stable formulation of exenatide |
| 02/26/2009 | WO2009005469A3 The use of compounds such as pyridoxal derivatives for the treatment of diabetes or diseases associated with the metabolic syndrome |
| 02/26/2009 | WO2008156331A3 Novel use of lignan compounds |
| 02/26/2009 | WO2008094222A3 Porphyrin catalysts and methods of use thereof |
| 02/26/2009 | WO2008090585A3 Soluble forms of inclusion complexes of histone deacetylase inhibitors and cyclodextrins, their preparation processes and uses in the pharmaceutical field |
| 02/26/2009 | WO2008030579A3 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 02/26/2009 | US20090054526 Inhibitors of anorexic lipid hydrolysis for the treatment of eating disorders |
| 02/26/2009 | US20090054513 Method of managing blood glucose levels, insulin levels and/or insulin receptor functionality in individuals with diabetes, polycystic ovarian syndrome and/or alzheimer's disease |
| 02/26/2009 | US20090054512 Use of organic compounds |
| 02/26/2009 | US20090054508 Igf-1r inhibitor |
| 02/26/2009 | US20090054506 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 02/26/2009 | US20090054502 Benzimidazole Derivative and Use as Angiotensin II Antagonist |
| 02/26/2009 | US20090054495 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis |
| 02/26/2009 | US20090054494 Peroxisome proliferator-activated receptor agonists; insulin resistance; neurodegenerative disorders ; N-{2-[4-(5-Isopropyl-[1,3,4]thiadiazol-2-ylsulfamoyl)-phenyl]-ethyl}-2-methoxy-4-trifluoromethyl-benzamide |
| 02/26/2009 | US20090054493 Thiazole derivatives as ppar delta ligands and their manufacturing process |
| 02/26/2009 | US20090054491 Use |
| 02/26/2009 | US20090054484 Substituted heteroaryl benzofuran acids |
| 02/26/2009 | US20090054479 Fused heterocyclic derivatives as ppar modulators |
| 02/26/2009 | US20090054475 treatment of Type II diabetes and other diseases associated with poor glycemic control |
| 02/26/2009 | US20090054474 2-[N-[3-(N-cyclopentylmethyl-N-ethyl)amino-6-methoxypyridin-2-yl]methyl-N-(3-trifluoromethylbenzyl)]amino-5-(2-methylthioethoxy)pyrimidine, having cholesterol ester transfer protein inhibitory activity, used for treating hyperlipidemia and arteriosclerotic diseases |
| 02/26/2009 | US20090054473 Therapy for complications of diabetes |
| 02/26/2009 | US20090054472 Pyrazolopyrimidine Derivatives or Pharmaceutically Acceptable Salts Thereof |
| 02/26/2009 | US20090054465 N-hydroxyacrylamide compounds |
| 02/26/2009 | US20090054459 Substituted indoles |
| 02/26/2009 | US20090054457 Substituted heterocyclic compounds |
| 02/26/2009 | US20090054450 Compositions and methods of use for treating or preventing lipid related disorders |
| 02/26/2009 | US20090054444 2(R)-2-(4-cyclopropanesulfonylphenyl)-N-(1-methylpyrazol-3-yl)-3-((R)-3-oxocyclopentyl)propionamide, useful in the prophylaxis and treatment of hyperglycemia and diabetes; hypoglycemic and antidiabetic agents |
| 02/26/2009 | US20090054435 Phenoxyalkanoic Acid Compound |
| 02/26/2009 | US20090054434 Isoquinolone derivatives as phosphodiesterase 10 inhibitors |
| 02/26/2009 | US20090054431 Novel heterocycle compounds |
| 02/26/2009 | US20090054423 Niacin receptor agonists, compositions containing such compounds and methods of treatment |